Island Pharmaceuticals LtdASX: ILA

Investor webinar

· Issued by Island Pharmaceuticals Ltd via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Island Pharmaceuticals Ltd has announced an upcoming investor webinar. The webinar will cover updates on the Galidesivir development program and upcoming studies. Management will discuss objectives and timelines for the Marburg dose optimisation study. An interactive Q&A session will follow the presentation for shareholders.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

13 November 2026 ASX Announcement Investor webinar MELBOURNE Australia, 13 November 2026: Australian antiviral drug development and biodefence company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to invite shareholders and investors to attend an investor webinar on...

Island Pharmaceuticals Ltd on 6ix

Earlier from Island Pharmaceuticals

Later from Island Pharmaceuticals

All Island Pharmaceuticals news releases